A Johns Hopkins University backed App for COVID quarantine assistance
text_fields
Bengaluru: Those who isolate themselves at home after contracting the COVID can take the advantage of this Johns Hopkins University approved smartphone app that gives much-needed information related to the infection and the virus.
Vee+ Svasa, the app developed by Vee Technologies located in Bengaluru and Salem, provides educational videos, information about accessing local medical care and Covid vaccines. Apart from these, the app also delivers COVID related contents from various sources and the expertise of medical practitioners at Johns Hopkins University and Medicine in the US, a company statement claimed.
The Vee+ Svasa was also enriched by the inputs of nearly 100 teams of students from Sona College of Technology who competed for a Rs 1 lakh student prize. The winning teams that emerged from this competition -- Senthil Sivaraman S, Harsh Vardhan SM, Ragul P and Shreinik Jain U -- were chosen to support the app building and running process.
"We reached out to Johns Hopkins India Institute to give access to the globally accepted standard of care protocols for home isolation cases. For Indians battling the Covid pandemic, this would be immensely helpful," said Valliappa Foundation Trustee Chocko Valliappa.
The home quarantine app has a wealth of authentic information ranging from treating oneself at home to how to isolate oneself and protect others in the family, to tips for caregivers on measuring oxygen saturation levels as well as an easy-to-understand Covid treatment flowchart.
The information and health protocols presented in the app come only from authentic sources, such as Johns Hopkins University, the Indian Council of Medical Research (ICMR) as well as the All India Institute of Medical Sciences (AIIMS).
The app will also feature existing services offered by state governments like locating hospital beds, vaccination centres, and doctors on teleconsultation in key cities.
The app is now available on Google Play Store while the iOS version of the app will be launched soon. (With IANS inputs)
